RELAPSED/REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (R/R SLE)

Clinical trials for RELAPSED/REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (R/R SLE) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (R/R SLE) trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (R/R SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Gene therapy trial targets tough autoimmune cases

Disease control Not yet recruiting

This early-stage study tests a new treatment called LVIVO-TaVec400 in 44 people with severe autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis that have not responded to standard therapies. The main goals are to check safety and find the right dose. This is…

Matched conditions: RELAPSED/REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (R/R SLE)

Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

RELAPSED/REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (R/R SLE)

Get alerted when new RELAPSED/REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (R/R SLE) trials appear

Gene therapy trial targets tough autoimmune cases